Country: Kanada
Bahasa: Inggeris
Sumber: Health Canada
CHLORHEXIDINE GLUCONATE
COLGATE-PALMOLIVE CANADA INC
A01AB03
CHLORHEXIDINE
0.12%
MOUTHWASH
CHLORHEXIDINE GLUCONATE 0.12%
BUCCAL
473ML
Prescription
MISCELLANEOUS ANTI-INFECTIVES
Active ingredient group (AIG) number: 0107629007; AHFS:
CANCELLED POST MARKET
2022-03-30
_Page 1 of 19_ PRODUCT MONOGRAPH CHLORHEXIDINE GLUCONATE ORAL RINSE Chlorhexidine Gluconate 0.12% Oral Rinse Liquid, USP 0.12% Chlorhexidine Gluconate Antigingivital Oral Rinse Colgate-Palmolive Canada Inc. Two Morneau Shepell Centre, 5 th Floor, 895 Don Mills Road, Toronto, Ontario M3C 1W3 Submission Control No.: 207101 Date of Preparation: August 17, 2017 _Page 2 of 19_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION.....................................................3 SUMMARY PRODUCT INFORMATION ................................................................3 INDICATIONS AND CLINICAL USE ......................................................................3 CONTRAINDICATIONS .........................................................................................3 WARNINGS AND PRECAUTIONS ........................................................................4 ADVERSE REACTIONS.........................................................................................6 DOSAGE AND ADMINISTRATION ........................................................................6 OVERDOSAGE .....................................................................................................7 ACTION AND CLINICAL PHARMACOLOGY ........................................................8 STORAGE AND STABILITY ..................................................................................9 SPECIAL HANDLING INSTRUCTIONS ................................................................9 DOSAGE FORMS, COMPOSITION AND PACKAGING .....................................10 PART II: SCIENTIFIC INFORMATION ..........................................................................11 PHARMACEUTICAL INFORMATION..................................................................11 CLINICAL TRIALS ................................................................................................12 DETAILED PHARMACOLOGY ............................................................................13 MICROBIOLOGY .............................. Baca dokumen lengkap